| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A functional −77T>C polymorphism in XRCC1 is associated with risk of breast cancer
|
Liu, Li
|
|
2010
|
125 |
2 |
p. 479-487
|
article
|
| 2 |
A high prevalence of BRCA1 mutations among breast cancer patients from the Bahamas
|
Donenberg, Talia
|
|
2010
|
125 |
2 |
p. 591-596
|
article
|
| 3 |
Association between two polymorphisms of ABCB1 and breast cancer risk in the current studies: a meta-analysis
|
Lu, Pei-Hua
|
|
2010
|
125 |
2 |
p. 537-543
|
article
|
| 4 |
Association of age and overall survival in capecitabine-treated patients with metastatic breast cancer in clinical trials
|
Blum, Joanne L.
|
|
2010
|
125 |
2 |
p. 431-439
|
article
|
| 5 |
Cadmium concentration in biological media of breast cancer patients
|
Strumylaite, Loreta
|
|
2010
|
125 |
2 |
p. 511-517
|
article
|
| 6 |
Decreased expression of EZH2 is associated with upregulation of ER and favorable outcome to tamoxifen in advanced breast cancer
|
Reijm, E. A.
|
|
2010
|
125 |
2 |
p. 387-394
|
article
|
| 7 |
Enhanced serine production by bone metastatic breast cancer cells stimulates osteoclastogenesis
|
Pollari, Sirkku
|
|
2010
|
125 |
2 |
p. 421-430
|
article
|
| 8 |
Evidence on the association between NQO1 Pro187Ser polymorphism and breast cancer risk in the current studies: a meta-analysis
|
Yuan, Weiguang
|
|
2010
|
125 |
2 |
p. 467-472
|
article
|
| 9 |
HER2 status in a population-derived breast cancer cohort: discordances during tumor progression
|
Wilking, Ulla
|
|
2010
|
125 |
2 |
p. 553-561
|
article
|
| 10 |
High immunogenic potential of p53 mRNA-transfected dendritic cells in patients with primary breast cancer
|
Met, Özcan
|
|
2010
|
125 |
2 |
p. 395-406
|
article
|
| 11 |
Individual responses to chemotherapy-induced oxidative stress
|
Il’yasova, Dora
|
|
2010
|
125 |
2 |
p. 583-589
|
article
|
| 12 |
Lack of association between ATM C.1066-6T > G mutation and breast cancer risk: a meta-analysis of 8,831 cases and 4,957 controls
|
Ding, Hong
|
|
2010
|
125 |
2 |
p. 473-477
|
article
|
| 13 |
Lack of association between HER2 codon 655 polymorphism and breast cancer susceptibility was not credible: appraisal of a recent meta-analysis
|
Lu, Pei-Hua
|
|
2010
|
125 |
2 |
p. 597-598
|
article
|
| 14 |
Large genomic rearrangements of the BRCA1 and BRCA2 genes: review of the literature and report of a novel BRCA1 mutation
|
Sluiter, Michelle D.
|
|
2010
|
125 |
2 |
p. 325-349
|
article
|
| 15 |
Need for clarification of results in the recent meta-analysis about SULT1A1 codon 213 polymorphism and breast cancer risk
|
Lu, Pei-Hua
|
|
2010
|
125 |
2 |
p. 599-600
|
article
|
| 16 |
No significant association results obtained from significant association evidence: the ongoing uncertainty of TP53 codon 72 polymorphism and breast cancer risk
|
Lu, Pei-Hua
|
|
2010
|
125 |
2 |
p. 601-603
|
article
|
| 17 |
Phase I trial of oral mTOR inhibitor everolimus in combination with trastuzumab and vinorelbine in pre-treated patients with HER2-overexpressing metastatic breast cancer
|
Jerusalem, Guy
|
|
2010
|
125 |
2 |
p. 447-455
|
article
|
| 18 |
Polymorphisms of the nuclear receptor pregnane X receptor and organic anion transporter polypeptides 1A2, 1B1, 1B3, and 2B1 are not associated with breast cancer risk
|
Justenhoven, Christina
|
|
2010
|
125 |
2 |
p. 563-569
|
article
|
| 19 |
Possible risk modifications in the association between MnSOD Ala-9Val polymorphism and breast cancer risk: subgroup analysis and evidence-based sample size calculation for a future trial
|
Chen, Yun
|
|
2010
|
125 |
2 |
p. 495-504
|
article
|
| 20 |
Potent CYP2D6 Inhibiting drugs do not increase relapse rate in early breast cancer patients treated with adjuvant tamoxifen
|
Siegelmann-Danieli, Nava
|
|
2010
|
125 |
2 |
p. 505-510
|
article
|
| 21 |
RAD51 135G>C polymorphism and breast cancer risk: a meta-analysis
|
Zhou, Guo-Wu
|
|
2010
|
125 |
2 |
p. 529-535
|
article
|
| 22 |
Relationship between diabetes and risk of second primary contralateral breast cancer
|
Li, Christopher I.
|
|
2010
|
125 |
2 |
p. 545-551
|
article
|
| 23 |
Risk of aggressive breast cancer in women of Han nationality carrying TGFB1 rs1982073 C allele and FGFR2 rs1219648 G allele in North China
|
Chen, Xiao-Hui
|
|
2010
|
125 |
2 |
p. 575-582
|
article
|
| 24 |
Safety of avoiding routine use of axillary dissection in early stage breast cancer: a systematic review
|
Pepels, Manon J.
|
|
2010
|
125 |
2 |
p. 301-313
|
article
|
| 25 |
Soy isoflavones consumption and risk of breast cancer incidence or recurrence: a meta-analysis of prospective studies
|
Dong, Jia-Yi
|
|
2010
|
125 |
2 |
p. 315-323
|
article
|
| 26 |
Stimulation of retinoic acid-induced functional sodium iodide symporter (NIS) expression and cytotoxicity of 131I by carbamazepine in breast cancer cells
|
Willhauck, Michael J.
|
|
2010
|
125 |
2 |
p. 377-386
|
article
|
| 27 |
Targeting mutant p53 protein and the tumor vasculature: an effective combination therapy for advanced breast tumors
|
Liang, Yayun
|
|
2010
|
125 |
2 |
p. 407-420
|
article
|
| 28 |
The β2-adrenergic receptor and Her2 comprise a positive feedback loop in human breast cancer cells
|
Shi, Ming
|
|
2010
|
125 |
2 |
p. 351-362
|
article
|
| 29 |
The association between two polymorphisms in pre-miRNAs and breast cancer risk: a meta-analysis
|
Gao, Lin-Bo
|
|
2010
|
125 |
2 |
p. 571-574
|
article
|
| 30 |
The impact of an aromatase inhibitor on body composition and gonadal hormone levels in women with breast cancer
|
Londen, G. J. van
|
|
2010
|
125 |
2 |
p. 441-446
|
article
|
| 31 |
The PHSCN dendrimer as a more potent inhibitor of human breast cancer cell invasion, extravasation, and lung colony formation
|
Yao, Hongren
|
|
2010
|
125 |
2 |
p. 363-375
|
article
|
| 32 |
Vascular endothelial growth factor receptor 2 and downstream p38 mitogen-activated protein kinase are possible candidate markers of intrinsic resistance to adjuvant endocrine treatment in steroid receptor positive breast cancer
|
Linderholm, Barbro K.
|
|
2010
|
125 |
2 |
p. 457-465
|
article
|
| 33 |
Vegetable intake is associated with reduced breast cancer recurrence in tamoxifen users: a secondary analysis from the Women’s Healthy Eating and Living Study
|
Thomson, Cynthia A.
|
|
2010
|
125 |
2 |
p. 519-527
|
article
|
| 34 |
VEGF 936C>T polymorphism and breast cancer risk: evidence from 5,729 cases and 5,868 controls
|
Gu, Dongying
|
|
2010
|
125 |
2 |
p. 489-493
|
article
|
Journal description